Thu, Jul 31, 2014, 11:13 PM EDT - U.S. Markets closed


% | $
Click the to save as a favorite.

NPS Pharmaceuticals, Inc. Message Board

  • faosto faosto Aug 8, 2013 6:43 PM Flag

    Pretend that AEGR is at $40 right now

    Even though AEGR is at $92. That's kind of the situation here. NPSP is at $19. It should be at $40.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • And I think if the CEO is even 70% accurate, the market potential of Gattex and Natpara dwarfs AEGR's peak revenues. Why am I comparing NPSP to AEGR? Very similar companies going after rare diseases / small populations. AEGR has Juxtapid for homozygous familial hypercholesterolaemia and NPSP has Gattex for SBS. Both are priced at $300,000. But the market for Gattex, if the CEO is correct, could be as large as 17,000 globally. (12,000 plus 5,000 US). The market for Juxtapid is 3,000. And the CEO now says that NATPARA could be as large a market revenue-wise as Gattex. What I just heard today tells me that NPSP is a double or triple from here, at least. It is also going to get courted heavily by big pharma. I wouldn't be surprised if Roche abandons pursuit of Alexion and switches over to NPSP.

27.94-1.35(-4.61%)Jul 31 3:59 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.